Mentioned it to pfeffer? You don't see anyone taking pictures with Matt, do you? I don't care for him much, truth be told, he's no more than okay in my book, but I'll admit my book is full of unsubstantiated bias. There's just something about him.

A PR would be great, though, as long as it doesn't announce that due to the overwhelming popularity of Afrezza, the Affinity 1 trial is being held over for a couple more months!

MNKD has been giving us all a lot of excitement for the last few months, and that's part of the reason at least some of us invested. My other significant biotech investment is putting people to sleep!